Pathogenic bacteria deliver effector proteins into host cells through the type III secretion apparatus to modulate the host function. We identify a family of proteins, homologous to the type III effector Cif from enteropathogenic Escherichia coli, in pathogens including Yersinia, Photorhabdus, and Burkholderia that contain functional type III secretion systems. Like Cif, this family of proteins is capable of arresting the host cell cycle at G2/M. Structure of one of the family members, Cif homolog in Burkholderia pseudomallei (CHBP), reveals a papain-like fold and a conserved Cys-His-Gln catalytic triad despite the lack of primary sequence identity. For CHBP and Cif, only the putative catalytic Cys is susceptible to covalent modification by E-64, a specific inhibitor of papain-like cysteine proteases. Unlike papain-like enzymes where the S2 site is the major determinant of cleavage-site specificity, CHBP has a characteristic negatively charged pocket occupying surface areas corresponding to the S1/S1 site in papain-like proteases. The negative charge is provided by a conserved aspartate, and the pocket best fits an arginine, as revealed by molecular docking analysis. Mutation analysis establishes the essential role of the catalytic triad and the negatively charged pocket in inducing cell cycle arrest in host cells. Our results demonstrate that bacterial pathogens have evolved a unique papain-like hydrolytic activity to block the normal host cell cycle progression.
G
ram-negative bacterial pathogens, such as Shigella, Salmonella, Yesinia, and enteropathogenic Escherichia coli (EPEC), employ a specialized type III secretion system (TTSS) to inject effector proteins into host cells (1) . These effectors function to interfere with various host signal transduction pathways, most frequently the innate immune system (2) , for the benefits of pathogen survival and systemic infection (3, 4) . Elucidating biochemical functions of type III effectors, particularly those conserved among different pathogens, has greatly promoted our understanding of novel yet common mechanisms of bacterial pathogenesis (5) (6) (7) .
In addition to the innate immune pathway, recent studies suggest that the host cell cycle machinery represents an emerging target of bacterial toxins, including some type III effectors (8) (9) (10) (11) . The Shigella type III effector IpaB binds directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/ cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G 2 /M phase (9) . This serves as an important strategy for Shigella to colonize the gut epithelium efficiently. Another bacterial toxin called cytolethal distending toxin (CDT) uses a DNase I-like activity to trigger the DNA damage checkpoint and block the host cell cycle at the G 2 /M transition (12, 13) . Similarly, a G 2 /M arrest phenotype is observed upon infection of epithelial cells by certain strains of EPEC because of the activity of a newly identified type III effector called Cif (cycle-inhibiting factor) (14) . In contrast to CDT, Cif does not activate the DNA damage checkpoint (15) . Interestingly, a recent study shows that post-G 2 cells infected with Cif-expressing EPEC are instead arrested in the G 1 phase, not the G 2 /M phase (16) . Despite the strikingly abnormal cell cycle distribution induced by Cif, its biochemical activity and the underlying mechanism of Cif function remain completely unknown.
In this work, we identify a family of known and putative type III effectors from Yersinia, Photorhabdus, and Burkholderia showing sequence homology to Cif, and we demonstrate that they all harbor a sufficient and potent G 2 /M arrest activity. The crystal structure of Cif homolog in Burkholderia pseudomallei (CHBP) reveals a papain-like fold with a well-conserved Cys-His-Gln catalytic triad. The Cys is susceptible to covalent modification by E-64, a papain family-specific inhibitor. A characteristic negatively charged pocket that could best fit an arginine likely serves as a distinct substratebinding subsite. Mutations disrupting the catalytic triad or the negatively charged pocket abolish cell cycle arrest function of the Cif family. Our results demonstrate that bacterial pathogens have evolved a unique papain-like hydrolytic activity to target and paralyze the eukaryotic cell cycle machinery.
Results

Identification of a Type III Effector Family of Cell Cycle Modulators.
EPEC Cif contains 282 aa with no domains recognized by SMART (http://smart.embl-heidelberg.de/) or Pfam (http://pfam.janelia.org/). Extensive sequence analysis employing PSI-BLAST iterations (17) revealed no homologous proteins with known functions and instead led to identification of three new homologous bacterial proteins. They are named CHYP (Cif homolog in Yersinia pseudotuberculosis), CHPL (Cif homolog in Photorhabdus luminescens), and CHBP. As shown in Fig. 1A , CHYP has the highest degree of sequence homology to Cif (Ϸ54% identity and Ϸ70% similarity); CHPL and CHBP are distantly related and only exhibit Ϸ20% sequence identity to Cif. The sequence conservation among the entire Cif family lies mainly in the middle and C-terminal regions, and their more diverse N-terminal sequences agree with the prediction that they are all TTSS effectors (see below).
Similarly to Cif-harboring EPEC, Y. pseudotuberculosis causes gastroenteritis in rodents, and CHYP can only be identified in Y. pseudotuberculosis YPIII strain. P. luminescens is a symbiont of nematodes, and the infection kills a broad spectrum of insects. The gene encoding CHPL is present in the genome of P. luminescens TTO1 strain, which contains an unprecedented large number of potential virulence genes (18) and a TTSS cluster essential for colonization in insects (19) . B. pseudomallei, classified as a category B agent by the US Centers for Disease Control and Prevention, is a potential bioterrorism agent. Infection with the bacteria causes melioidosis, a severe human disease with a high mortality (20-50%) and endemic to areas of Southeast Asia and Northern Australia (20) . Notably, sequenced genomes of Ͼ10 different B. pseudomallei clinical isolates all contain the CHBP gene, which is absent from genomes of closely related Burkholderia thailandensis and Burkholderia mallei that usually do not cause human melioidosis. Comparative genomic analysis of B. pseudomallei and other related bacteria reveals numerous horizontally acquired genomic islands and three TTSSs (21) . Among them, TTSS3 shares homology with the Inv/Mxi-SpaTTSS cluster of Shigella flexneri and Salmonella typhimurium and is important for infection of cultured cells and virulence in mice (22, 23) .
Cif is carried in a prophage-acquired region outside of the type III locus in EPEC (14, 24) . The CHYP ORF in Y. pseudotuberculosis YPIII is next to a gene predicted to encode a transposase fragment. The CHBP ORF in B. pseudomallei K96243, located adjacent to TTSS1 (21) , is also flanked by transposase-encoding DNA fragments. The CHPL ORF is predicted to reside in a phage-like genomic region in P. luminescens TTO1 (18) . Because Cif is a TTSS effector and its gene is acquired through phage-mediated horizontal transfer (14, 24) , it is not surprising that Cif homologs are also candidate substrates of their TTSS, and their genes may evolve through lateral transfer during evolution. With the ongoing microbial genome-sequencing efforts, more Cif family members will likely be found in other TTSS-containing bacterial pathogens.
Despite the limited overall sequence identity, all of the Cif family members harbor several conserved patches of residues, including Cys-109 and His-165 (numbered in Cif) and similar predicted secondary structure arrangements (Fig. 1A) . We therefore tested whether Cif homologs indeed share Cif activity of inhibiting eukaryotic cell cycle progression. Similar to that observed with EPEC infection, ectopically expressed EGFP-Cif induced marked accumulation of 293T cells with 4C DNA content (Fig. 1B) . Cells transfected with EGFP-CHBP or EGFP-CHPL were also arrested at the G 2 /M transition (Fig. 1B) . These results suggest that CHBP from B. pseudomallei and CHPL from P. luminescens are functional homologs of Cif from EPEC, and the entire Cif family effectors likely employ a similar biochemical mechanism in blocking the host cell cycle progression.
Overall Structure of CHBP. To understand the nature of the Cif family of cell cycle modulators and gain mechanistic insights into their functions, we purified recombinant CHBP-N48 (truncation of the N-terminal 47 residues) and determined the 2.1-Å crystal structure by Se-SAD (single-wavelength anomalous diffraction) (Fig. 2) . Details of the crystallographic analysis are listed in supporting information (SI) Table S1. The structure contains a dimer of CHBP in one asymmetric unit (Fig. S1 ). Dimerization buries Ϸ10% of the total solvent-accessible area for one monomer. Few specific interactions exist between the two CHBP monomers, and recombinant CHBP, CHPL, or Cif exclusively stays as monomers in solution. These findings suggest that the CHBP dimer observed in the structure likely results from crystal packing and lacks biological relevance. Structures of the two monomers are nearly identical with a C ␣ backbone rmsd of 0.32 Å. Thus, hereafter, we limit our discussion to one CHBP molecule (Chain A, Fig. S1 ). The final model contains residues 78-327 of CHBP and misses the Cterminal last amino acid (Gly-328), residues 221-224 in a loop region, and the N-terminal 30 residues because of the lack of electron density. The N-terminal region in the Cif family shows little sequence conservation (Fig. 1 A) and is expected to serve as the type III secretion signal. When directly delivered into HeLa cells, recombinant CHBP-N48 was fully active in inducing a G 2 arrest (Fig. S2 A) . Progressive deletion of the N terminus of Cif until residue 37 (Cif-N38), approximately corresponding to Arg-85 in CHBP, had no effects on its G 2 arrest activity, but further trunca- tion of the N-terminal 51 residues (Cif-N52) resulted in a nonfunctional Cif (Fig. S2B ). These data suggest that the N-terminal region of the Cif family is dispensable for cell cycle arrest and that the obtained structure of CHBP (residues 78-327) contains a fully functional effector entity.
The CHBP structure with an overall dimension of 56 Å ϫ 37 Å ϫ 46 Å belongs to the ␣ ϩ ␤ class according to the SCOP nomenclature (http://scop.mrc-lmb.cam.ac.uk/scop/). The structure is composed of 14 ␣-helices (␣1-␣14) and four ␤-strands (␤A-␤D) that form an antiparallel ␤-sheet and can be divided into two lobes. The ␤-sheet, together with several surrounding long linking loops and ␣6-␣13, form a compact core globular lobe named the CG lobe. Extensive hydrophobic interactions play important roles in stabilizing the CG lobe structure. ␣1-␣5, together with the extreme C-terminal ␣14, compose the other lobe named helical extension lobe (HE lobe). In the HE lobe, ␣1 and ␣14 form a helix pair and pack against the CG lobe at its bottom left side. The short helices ␣2 and ␣3 further stack on top of the ␣1/␣14 helix pair and connect it with ␣4 and ␣5. The long ␣4 projects upward and away from the CG lobe into the solvent. ␣5, perpendicular to ␣4, is connected to ␣6 in the CG lobe through an extended long loop (residues 144-155), which generates a tunnel between the HE and CG lobes. Three interactions could be found between the CG and HE lobes. Tyr-110 in the loop linking ␣2 and ␣3 uses its carbonyl oxygen and phenol oxygen to make two hydrogen bond contacts with the N of Lys-165 and the side-chain amide nitrogen of Asn-161 from ␣6, respectively. The side-chain amide nitrogen of Asn-320 from the middle of ␣14 is also hydrogen-bonded to the carbonyl oxygen of Leu-166 in ␣6. Certain EPEC strains harboring missense Cif mutants truncated from Asn-273 (equivalent to Asn-320 in CHBP) to the C terminus are deficient in inducing cell cycle arrest (14) . This could be explained by the possible role of Asn-320 and ␣14 in stabilizing the CG lobe (the catalytic domain, see below) or possibly the whole CHBP molecule. Indeed, forced high-level expression of the natural missense mutant could still induce cell cycle arrest in 293T cells (Fig. S2B) . Interestingly, deletions of ␣4 and ␣5 in the HE lobe of CHBP, which is unlikely to affect the structural integrity of the CG lobe, abolished the cell cycle arrest function (Fig. S2 A) , implicating a possible role of the protruding ␣4 and ␣5 and the HE lobe in mediating substrate recognition.
Papain-Like Fold and Potential Catalytic Triad. We further subjected the structure of the CG lobe to DALI searches (25) . Remarkably, hydrolytic enzymes with a similar papain-like fold dominate the list of hits returned from the DALI server with the top five unique ones (Z-score Ͼ4.0) being Pseudomonas avirulence protein AvrPphB protease [Protein Data Base (PDB) ID code 1UKF] (26), Ufm1-specific protease 1 (PDB ID code 2Z84) (27) , the N-terminal papain-like catalytic domain of Phytochelatin synthase (ALR0975 from cyanobacterium Nostoc; PDB ID code 2BU3) (28), herpesvirus-encoded ubiquitin-specific protease M48 (PDB ID code 2J7Q) (29) , and the papain-like domain of a Vibrio toxin secretion protein (PDB ID code 3B79). The first four have an intact Cys-His-Asp catalytic triad that exhibit cysteine protease activities in vitro. Generally, the N-terminal region of papain-like proteases is largely helical whereas the C-terminal part is enriched in ␤-strands (7). These characteristics are also present in the CG lobe of CHBP (Fig. 3A) . Furthermore, the papain-like fold features a common structural core comprising one helix (green in Fig. 3A ) and one four-strand antiparallel ␤-sheet (pink in Fig. 3A ), which provides a framework to support and position the catalytic triad residues precisely within a V-shape active-site cleft. The CHBP structure evidently bears a similar structural core (␣6 and ␤A-D, Fig. 3A) , and the corresponding residues are within the most conserved region (Fig. 1 A) . Despite these similarities, structural organization of CHBP outside of the core helix and four-strand sheet does not resemble that of any other papain-like enzyme. For papain-like hydrolytic enzymes, a reactive Cys acts as a catalytic nucleophile, and a nearby His functions as a general base to deprotonate the Cys sulfhydryl group and increase its nucleophilicity. The His imidazolium ring is further hydrogen-bonded to a third catalytic residue, usually an Asp or Asn. The Cys, His, and Asp/Asn, collectively referred to as the catalytic triad, are positioned by the common structural core; the Cys is usually located at the N terminus of the helix, and the His and the Asp/Asn are provided by the ␤-sheet and linking loops (Fig. 3A) . CHBP also contains conserved Cys and His at corresponding positions, i.e., Cys-156 at the N terminus of ␣6 and His-211 in ␤B. Superimposition of Cys-156 and His-211 of CHBP onto Cys-25 and His-159 of papain or equivalent catalytic residues of other papain-like enzymes showed a remarkable fit, brought the core ␣-helices to a nearly identical position (Fig. 3B) , highlighting the structural similarity between CHBP and papain-like enzymes. Moreover, the Cys and His in CHBP and papain-like enzymes adopt a similar geometry, indicating that CHBP likely uses the two residues to carry out a hydrolytic reaction. In accordance, Cys-156 is solvent-exposed, and the sulfur atom is surrounded by extra electron density that results from oxidation of the sulfhydryl group into sulfonic acid (Fig. S3) . Similar oxidation has been observed in the structure of AvrPphB (26) and other papain-like enzymes (30) . This phenomenon supports the expected lowered pK a and high reactivity of Cys-156 as a catalytic nucleophile.
Upon superimposition, Gln-231 in CHBP was found to be located at a position similar to that occupied by the third catalytic residue in papain-like enzymes (Fig. 3B ). Although C ␣ of Gln-231 is 3 Å apart from that of Asn-175 in papain, their side chains point toward the same direction, and the amide oxygen atoms are proximal to each other. These structural features should allow for Gln-231 to polarize His-211 during catalysis, analogous to the situation in papain-like enzymes. Taken together, Cys-156, His-211, and Gln-231 of CHBP form a potential catalytic triad that resembles that of papain-like hydrolytic enzymes. Notably, all of the three residues are conserved among the entire Cif family (Fig. 1 A) , suggesting that other family members likely share a similar catalytic triad and the associated hydrolytic activity.
During catalysis by papain-like enzymes, the Cys-mediated nucleophilic attack on a substrate carbonyl carbon turns the carbonyl oxygen into an oxyanion. In papain, the oxyanion is held by the backbone amide of Cys-25 and the side-chain amide of Gln-19 that form the oxyanion hole. In CHBP, the main-chain amide of Leu-234 is the structural counterpart of the side-chain amide of Gln-19 in papain (Fig. 3C) , suggesting its potential role in oxyanion hole formation. Gln-19 in papain and equivalent residues in other papain family enzymes are usually located on the loop preceding the core helix harboring the catalytic Cys. The loop turns almost 180°t o bring Gln-19 and Cys-25 into proximity to allow for oxyanion hole formation (Fig. 3C) . However, the corresponding loop in CHBP apparently lacks such a turn, and Leu-234 is instead provided by another loop linking ␤C and ␣8.
Evidence for Cysteine Protease Activity and Distinct Substrate-Binding
Sites. E-64, trans-epoxysuccinyl-L-leucylamido (4-guanidino)butane, potently inhibits the papain-like cysteine protease activity by specifically and covalently modifying the catalytic cysteine sulfhydryl group (7, 31, 32) . After incubation of recombinant Cif or CHBP with E-64, a mass increase of 357 Da was observed on the putative catalytic cysteine in both proteins when analyzed by mass , and S1Ј sites and the corresponding surface in CHBP (Right). The surface is colored by relative electrostatic potential (obtained by using APBS plug-in in PyMOL), with red and blue denoting negatively and positively charged surfaces, respectively. (C) Molecular docking of an arginine into the negatively charged pocket occupying the S1/S1Ј site. A library of 400 dipeptides was searched by in silico molecular docking, and arginine was found to be the only residue that fits into the pocket. Shown as sticks is one of the two possible binding poses of the arginine, in which its guanidinium group makes an ionic and a hydrogen bond contact with Asp-233 and Leu-209, respectively. The pocket is shown in surface presentation. spectrometry (Fig. 4A and Fig. S4 ). This mass increase exactly correlates with E-64 modification. Remarkably, all of the nine deduced cysteine-containing peptides resulting from complete trypsin digestion of Cif and CHBP were identified by mass spectrometry, but only the catalytic cysteines were found to be conjugated by E-64 (Fig. 4A and Fig. S4) . Thus, the conserved cysteine in the Cif family harbors chemical properties similar to those of the catalytic cysteine in papain-like proteolytic enzymes, further supporting the idea that the Cif family members are structural homologs of papain-like enzymes.
For papain-like cysteine proteases, certain areas around the catalytic triad cleft are responsible for substrate binding and the cleavage site specificity. Comparison of the surface of CHBP around the catalytic cleft with those of papain-like proteases cathepsin B, cruzain, and staphopain bound with inhibitors occupying the S/SЈ sites reveals potential substrate-binding sites and their structural features (Fig. 4B) . Usually, papain family proteases harbor a characteristic S2 site, and the P2 residue in the substrate largely contributes to the cleavage site selectivity (26) . The corresponding S2 site in CHBP appears to be shallow and lacks distinctive structure. Instead, a deep and highly negatively charged pocket, generated in part by a lid-like loop between ␤C and ␣8, occupies the S1/S1Ј site. The negative charge is mainly provided by a conserved Asp-233 (Fig. 1 A) . Neutralization of the negative charge by a D187N mutation in Cif resulted in a largely inactive effector in arresting the host cell cycle (see below). Asp-233 has no interactions with the catalytic triad residues and is likely not directly involved in catalysis. Based on these analyses, we propose that Asp-233 and the negatively charged pocket play a critical role in binding and specificity of the cleavage site in the substrate.
The pocket appears to accommodate a positively charged arginine side chain nicely. To test this prediction in an unbiased way, we searched for dipeptides from all of the 400 possible dipeptides by in silico molecular docking. A two-step protocol using a molecular docking program followed by refining and rescoring with a more computationally intensive molecular mechanics-based energy function (33) was applied to predict the binding poses of those proteinligand complexes. Regardless of the nature of the other amino acid, arginine is the only residue that fits into the negatively charged pocket (Table S2) . Two favorable binding poses of the arginine were identified from the docking simulation, both of which place C ␣ of the arginine at a close distance of Ϸ4 Å to the sulfur of Cys-156. In one pose illustrated in Fig. 4C , the arginine residue forms a strong bidentate interaction with Asp-233, donates a hydrogen bond to a backbone carbonyl oxygen of Leu-209, and forms an extra stacking interaction with His-211. In view of results of the docking analysis (Table S2) , we generated a recombinant GST protein fused to four tandem repeats of Asn-Gly-Arg-Gly or five copies of Asn-Arg-Gly followed by a C-terminal FLAG tag and assayed whether either of the inserted arginine-rich linkers could serve as an artificial proteolytic substrate for the Cif family of effectors. Unfortunately, no significant proteolytic activities of CHBP or Cif toward either of the purified GST fusion proteins were detected. This finding indicates that additional residues are likely required for efficient substrate recognition assuming that the Cif family indeed comprises proteolytic enzymes rather than another type of hydrolytic enzymes.
Putative Catalytic and Substrate-Binding Sites Are Essential for Cell
Cycle Arrest. Finally, we investigated the role of the presumed papain-like catalytic activity of the Cif family of type III effectors in inducing eukaryotic cell cycle arrest. Ectopic expression of the catalytic cysteine mutants (Cif C109S, CHBP C156S, or CHPL C128S) in 293T cells failed to induce a G 2 /M arrest in contrast to their wild-type counterparts (Fig. 5A) . Next, when equal amounts of recombinant wild-type CHBP or the catalytic triad mutant (C156S, H211N, or Q231A) were delivered directly into HeLa cells synchronized at the G 1 /S boundary, all of the catalytic triad mutants appeared to lose the ability to inhibit the cell cycle progression (Fig.   5B ). Finally, human EPEC strain E2348/69 harboring wild-type Cif induced an evident G 2 /M arrest. In contrast, mutations of the catalytic triad of Cif (C109S, C109A, H165N, and Q185A) abolished its cell cycle arrest activity during EPEC infection (Fig. 5C ). In the infection assay, we also included the D187N mutant of Cif, and we found that HeLa cells infected with the EPEC harboring the mutant progressed normally from G 2 phase to mitosis (Fig. 5C ). Taken together, our analysis demonstrates that the papain-like catalytic triad residues and the characteristic negatively charged substrate binding sites are essential for the Cif family of type III effectors to block the host cell cycle progression from G 2 to mitosis.
Discussion
The large majority of papain-like enzymes are cysteine proteases in nature. Nonprotease variants sharing the papain-like fold and catalytic triad have been shown to harbor hydrolytic activities such as arylamine N-acetyltransferase and transglutaminase. Indeed, reactions catalyzed by these nonprotease papain-like enzymes are also initiated by nucleophilic attack of a carbonyl group by the catalytic Cys and involve formation of an acylenzyme intermediate; and they differ from proteases by where the carbonyl group is in the substrate and/or which group further attacks the acylenzyme in- termediate and releases the enzyme. For instance, the Cys in transglutaminases attacks the side-chain carbonyl group of a glutamine residue, resulting in release of the ammonium cation; the acylenzyme intermediate is further attacked by the amine of a lysine, which generates an amide linkage between the side chains of the glutamine and lysine. In the case of acetyltransferase, the Cys attacks the carbonyl group in acetyl-CoA. E-64 with a peptide-like structure is remarkably selective for papain-like proteases and has minimal cross-reactivity with other types of papain-like enzymes (31) . The fact that the catalytic cysteine in CHBP and Cif is specifically modified by E-64 and the presence of the arginine-fit negatively charged pocket in the equivalent S1/S1Ј site favor the idea that the Cif family of effectors are likely cysteine proteases. However, it is certainly a possibility that the Cif family may catalyze a nonproteolytic reaction by using its papain-like catalytic triad. This question can only be answered definitively when the physiological targets/substrates of the Cif family of effectors are identified.
An emerging concept is that pathogenic bacteria of both the animal and plant kingdoms have evolved a large repertoire of effector proteins endowed with proteolytic/hydrolytic activities to interfere with host functions. A growing list of type III effectors or effector families with such activities includes, but is not limited to, the YopT/AvrPphB family (6, 7), the YopJ/AvrA/AvrBsT family (34), AvrRpt2 (35) , XopD (36), SseL (37) , and the AvrPphE family (38) . Interestingly, structure of Pasteurella multocida toxin, a highly potent mitogen and critical virulence factor in the pathogenesis of atrophic rhinitis, reveals a C-terminal AvrPphB-like protease domain required for the cellular function of the toxin (39) . Identification of the proteolytic activity and host targets of these effectors has significantly advanced our understanding of bacterial pathogenesis. Here, we add a papain-like hydrolytic activity to the arsenal of pathogenic effectors for thwarting normal functions of the host cell cycle machinery. Determining the nature of the eukaryotic substrate(s) of the Cif family of cell cycle modulators will likely shed new light on our understanding of eukaryotic cell cycle.
Finally, while this manuscript was being submitted for publication, Hsu et al. (40) reported the structure of the C-terminal fragment of Cif. Consistent with our observation, the analysis of Hsu et al. also suggests that Cif harbors a papain-like fold and catalytic triad. Structural comparison indicates a high degree of similarity between the Cif structure and the CG lobe of CHBP, further confirming that the entire Cif or CHBP family of type III effectors likely functions as papain-like enzymes in blocking the host cell cycle progression.
Materials and Methods
Genes encoding Cif, CHBP, and CHPL were amplified from bacterial genomic DNA. Recombinant proteins for crystallization or functional analysis were expressed and purified from E. coli. The crystal structure of CHBP was determined by Se-SAD. The rest of the information about reagents, detailed crystallization and structural determination, cell culture and cell cycle analysis, bacterial infection, E-64 labeling, and mass spectrometry analysis is presented in SI Materials and Methods.
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SI Materials and Methods
Plasmids and Reagents. For expression in enteropathogenic Escherichia coli (EPEC), cycle-inhibiting factor (Cif) was cloned into pBluescript II SK(Ϫ). For recombinant expression in E. coli, Cif homolog in Burkholderia pseudomallei (CHBP) was constructed into pGEX-6P (Amersham Biosciences). For transfection in mammalian cells, Cif family members were cloned into pCS2(ϩ) with an N-terminal EGFP tag. Truncation and deletion mutants were constructed by standard PCR cloning strategy, and point mutants were generated by the QuikChange site-directed mutagenesis kit (Stratagene). All of the plasmids were verified by DNA sequencing. Cell culture products were from Invitrogen, and all other chemicals were Sigma-Aldrich products unless noted.
Protein Purification and Crystallization. For expression, the BL21 (DE3) strain (Novagen) harboring the CHBP-N48 construct was induced for 8 h at 22°C in the presence of isopropyl-␤-thiogalactopyranoside after A 600 reached 0.8. The GST fusion protein was purified by glutathione-Sepharose resin, and the GST tag was removed by PreScission protease digestion. The protein was further purified by ion exchange chromatography followed by gel filtration chromatography (Superdex 200; Amersham Biosciences). The SeMet-labeled protein was expressed in the methionine-auxotrophic strain B834 (DE3) (Novagen) (1) and purified the same as that for the native protein. For crystallization, purified CHBP proteins were concentrated to 5 mg/mL in a buffer containing 50 mM Tris⅐HCl and 0.15 M NaCl (pH 7.9). Crystals of native and SeMet-labeled protein were obtained in 32% PEG 1000, 100 mM sodium cacodylate (pH 6.0), and 5% (vol/vol) glycerol in 7 days by using the hangingdrop vapor diffusion method at 20°C.
Data Collection, Structural Determination, and Refinement. The anomalous diffraction data (Se-Peak) for the SeMet-labeled CHBP crystal were collected at the KEK radiation facility at a wavelength of 0.9791 Å at 95 K and processed with HKL-2000 (2). The structure was determined and autobuilt by the Se-singlewavelength anomalous diffraction phasing method using the program PHENIX (3), which provided a 75% complete model. The remaining residues of the model were manually built with COOT (4). The structure was further refined to 2.1 Å by using native crystal data in PHENIX and Refmac5.0. The quality of both models was checked with PROCHECK program (5). Statistics of data collection and refinement are listed in Table S1 . All structural pictures were drawn by using PyMOL (http:// www.delanoscientific.com/).
Cell Culture, Transfection, EPEC Infection, and Cell Cycle Analysis.
293T and HeLa cells obtained from American Type Culture Collection were grown in Dulbecco's modified Eagle's medium (DMEM; HyClone) containing 10% FBS and 2 mM L-glutamine at 37°C in a 5% CO 2 incubator. Calcium phosphate precipitation was adopted for transfection of 293T cells. Purified recombinant proteins were delivered into HeLa cells by using Profect-P1 protein delivery reagent (Targeting Systems) according to the manufacturer's instructions. HeLa cells were synchronized at the G 1 /S boundary by double-thymidine block before protein delivery was performed in serum-free medium for 4 h. FBS was added back to 10%, and cells were further cultured for 14 h until the time of assay.
For EPEC infection, a single EPEC colony was inoculated into 0.5 mL of LB and statically cultured overnight at 37°C. On the day of infection, bacterial cultures were diluted by 1:30 in DMEM and further cultured at 37°C with 5% CO 2 for 3 h. Infection was carried out by adding the DMEM culture of EPEC directly to HeLa cells with a multiplicity of infection of 200:1, and the infection was usually continued for 1 h at 37°C in the 5% CO 2 incubator. Cells were then washed three times with PBS and cultured for 18 h in DMEM supplemented with 10% FBS and 200 g/mL gentamicin before cell cycle analysis.
To determine the cell cycle distribution, trypsin-treated HeLa cells were fixed and permealized in cold 70% ethanol followed by propidium iodide (PI) staining. DNA content was measured on Cell Lab Quanta SC flow cytometer (Beckman Coulter). To assay transiently transfected cells, trypsin-treated 293T cells were fixed in 3% formaldehyde and permealized in 70% ethanol. Both the PI signal for DNA content and EGFP signal were monitored simultaneously on the flow cytometer, and EGFPpositive cells were gated out and analyzed for PI signal.
E-64 Labeling and Mass Spectrometry Analysis. Twelve micrograms of Cif or CHBP-N48 protein was incubated overnight at 30°C in a buffer containing 25 mM Tris⅐HCl (pH 7.6), 150 mM NaCl, and 4 mM DTT, with or without 400 M E-64. Reactions were stopped by adding SDS loading buffer and subjected to SDS/ PAGE. For mass spectrometry analysis, protein gel bands were destained with 25 mM NH 4 HCO 3 and 50% methanol and reduced in 10 mM DTT for 40 min at 56°C followed by alkylation in 55 mM iodoacetamide for 1 h in the dark at 20°C. Proteins were then in-gel-digested with 10 ng/L sequencinggrade modified trypsin (Promega) in 50 mM NH 4 HCO 3 (pH 7.8) at 37°C overnight. The resulting tryptic peptides were extracted and analyzed on a LTQ mass spectrometer (Thermo; Fisher Scientific) by nano-HPLC/MS/MS in the data-dependent mode (MS scan mass range was from 350 to 2,000 Da, and the top three most abundant precursor ions from each MS scan were selected for MS/MS scans). The proteins were identified through database searches performed on an in-house Mascot server (version 2.2, Matrix Science). The mass tolerance was 2 Da for precursor ions and 0.5 Da for MS/MS scans. The following variable modifications were chosen for database search: cysteine carbamidomethylation, E-64 labeling of cysteine, and methionine oxidation. Left column, dipeptide sequence; right column, energy score of docked dipeptide/CHBP complex. The table includes all the 314 dipeptides, for which binding complex can be generated. Arginine and lysine residues are shown in bold and italics, respectively.
